90/019,425Closed-loop feedback-driven sympathetic neuromodulation for affect control9,345,880Closed

Status

Reexamination Certificate Issued

Filed

Feb 20, 2024

Last Updated

Apr 4, 2025

Art Unit

3992

Requester

LivaNova Inc.

Requester Law Firm

Fish & Richardson, P.C.

Requested By

Third Party

Patent OwnerInferred

Dilorenzo Biomedical LLC

Sector (CPC)

ALife Sciences & Consumer
A61Medical & Pharmaceutical
A61NElectrotherapy & Radiation Therapy

USPC

607Surgery: Light, Thermal, And Electrical Application

Reexam History (36 events)

Apr 4, 2025REEXInput Issue Number and Issue Date for Reexamination
Mar 25, 2025RXPUBSReexam Forwarded to Office of Publications
Mar 11, 2025MRNRCRX - Mail Notice of Intent to Issue a Reexam Certificate
Feb 27, 2025RXFWDXDate Forwarded to Examiner
Jan 15, 2025MRXG.RX - Mail Extension of Time Period for Response Granted
Jan 13, 2025RXC/SRCertificate of Service
Jan 13, 2025RXPET.Receipt of Petition in a Reexam
Nov 15, 2024MR.NFRX - Mail Reexam Non-Final Action
Oct 23, 2024IDSCInformation Disclosure Statement considered
Oct 23, 2024PA..Change in Power of Attorney (May Include Associate POA)
Oct 21, 2024RXC/SRCertificate of Service
Oct 21, 2024RXA...Response after Non-Final Action
Oct 21, 2024RXIDS.Information Disclosure Statement Filed
Oct 21, 2024WIDSInformation Disclosure Statement (IDS) Filed
Oct 21, 2024RXPA..Change in Power of Attorney (May Include Associate POA)
Aug 21, 2024MR.NFRX - Mail Reexam Non-Final Action
Jul 8, 2024RXFWDXDate Forwarded to Examiner
Apr 29, 2024RXLET.Miscellaneous Incoming Letter
Apr 29, 2024RXLET.Miscellaneous Incoming Letter
Mar 25, 2024MREXORX - Mail Ex Parte Request for Reexamination Granted
Mar 7, 2024IDSCInformation Disclosure Statement considered
Feb 26, 2024MRXNReexamination Formalities Notice Mailed
Feb 26, 2024DOCKCase Docketed to Examiner in GAU
Feb 26, 2024MRXNReexamination Formalities Notice Mailed
Feb 23, 2024RXPCOMCompletion of Preprocessing - Released to Assigned GAU
Feb 23, 2024RXNREQFDNotice of reexamination request filing date
Feb 23, 2024RXNREQAUNotice of assignment of reexamination request
Feb 23, 2024FTFIFITF set to NO - revise initial setting
Feb 23, 2024RXLITSRReexam Litigation Search Conducted
Feb 21, 2024RXTTLRPTTitle Report
Feb 20, 2024BIG.Entity Status Set To Undiscounted (Initial Default Setting or Status Change)
Feb 20, 2024WIDSInformation Disclosure Statement (IDS) Filed
Feb 20, 2024RXOSUBReceipt of Original Ex Parte Reexam Request
Feb 20, 2024RXIDS.RReexam - Information Disclosure Statement Filed by Third Party Requester
Feb 20, 2024RXOSUB.RReexamination requested by third party requester
Feb 20, 2024RXAF/DRReexam - Affidavit(s), Declaration(s) and/or Exhibit(s) Filed by Third Party Requester

Prosecution, PTAB & CAFC

PTAB Proceedings (IPR, PGR, CBM, DER)

None found

Federal Circuit (CAFC)

None found

Terminal Disclaimer

None found

Prosecution History

None found

Maintenance Fees

Grant
May 24, 2016
3.5-yr
Nov 24, 2019
Paid Nov 8, 2019
7.5-yr
Nov 24, 2023
Paid Nov 8, 2023
11.5-yr
Nov 24, 2027
Expiry
Sep 27, 2032

Entity Status

Large Entity

Expires

Sep 27, 2032 (6.5 yr remaining)

Term Adjustment

+2445 days (~6.7 yr)

Assignments

2006200720082009201020112012201320142015201620172018201920202021202220232024FiledDANIEL JOHN DILORENZODANIEL JOHN DILORENZODANIEL J DILORENZOBIONEURONICS CORPORATIONDILORENZO BIOMEDICAL, LLCNEUROVISTA CORPORATIONCYBERONICS, INC.DANIEL J DILORENZOLIVANOVA USA, INC.ARES CAPITAL CORPORATION, AS COLLATERAL AGENTACF FINCO I LP, AS COLLATERAL AGENTDILORENZO BIOMEDICAL, LLCDILORENZO BIOMEDICAL, LLCNEUROVISTA CORPORATIONSecurity InterestACF FINCO I LPReleaseARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERSReleaseLIVANOVA USA, INC.Security InterestGOLDMAN SACHS BANK USA, AS COLLATERAL AGENTRelease
AssignmentReel/Frame: 066621/0320Recorded: Feb 16, 2024

From

DANIEL JOHN DILORENZOInventor
Aug 1, 2005

To

BIONEURONICS CORPORATION

AssignmentReel/Frame: 017274/0287Recorded: Mar 8, 2006

From

DANIEL JOHN DILORENZOInventor
Mar 8, 2006

To

DILORENZO BIOMEDICAL, LLC

Name ChangeReel/Frame: 066624/0280Recorded: Feb 16, 2024

From

BIONEURONICS CORPORATION
Apr 27, 2007

To

NEUROVISTA CORPORATION

Security InterestReel/Frame: 066484/0594Recorded: Feb 16, 2024

From

NEUROVISTA CORPORATION
Sep 14, 2012

To

CYBERONICS, INC.

AssignmentReel/Frame: 066484/0639Recorded: Feb 16, 2024

From

NEUROVISTA CORPORATION
Feb 28, 2013

To

CYBERONICS, INC.

OtherReel/Frame: 055694/0903Recorded: Mar 23, 2021

From

DILORENZO BIOMEDICAL, LLC
Sep 2, 2014

To

DANIEL J DILORENZO

Name ChangeReel/Frame: 066624/0288Recorded: Feb 16, 2024

From

CYBERONICS, INC.
Jun 30, 2017

To

LIVANOVA USA, INC.

OtherReel/Frame: 053673/0675Recorded: Jun 17, 2020

From

LIVANOVA USA, INC.
Jun 17, 2020

To

ARES CAPITAL CORPORATION, AS COLLATERAL AGENT

OtherReel/Frame: 054881/0784Recorded: Dec 30, 2020

From

LIVANOVA USA, INC.
Dec 30, 2020

To

ACF FINCO I LP, AS COLLATERAL AGENT

AssignmentReel/Frame: 055692/0834Recorded: Mar 23, 2021

From

DANIEL J DILORENZOInventor
Mar 23, 2021

To

DILORENZO BIOMEDICAL, LLC

ReleaseReel/Frame: 057552/0378Recorded: Sep 20, 2021

From

ACF FINCO I LP
Aug 12, 2021

To

LIVANOVA USA, INC.

ReleaseReel/Frame: 057189/0001Recorded: Aug 16, 2021

From

ARES CAPITAL CORPORATION, AS AGENT FOR THE LENDERS
Aug 12, 2021

To

LIVANOVA USA, INC.

Security InterestReel/Frame: 057188/0001Recorded: Aug 16, 2021

From

LIVANOVA USA, INC.
Aug 13, 2021

To

GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT

AssignmentReel/Frame: 067508/0068Recorded: May 23, 2024

From

LIVANOVA INC.
Apr 22, 2024
LIVANOVA USA INC.
Apr 22, 2024

To

DILORENZO BIOMEDICAL, LLC

ReleaseReel/Frame: 069072/0874Recorded: Oct 30, 2024

From

GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
May 7, 2024

To

LIVANOVA USA, INC.